Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: Regeneron Pharmaceuticals Inc

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regeneron Pharmaceuticals Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Regeneron Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Regeneron Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is REGN. The reporting company's CIK number is 872589.

The total value of stock buying since 2005 is $0. The total value of stock sales is $100,580,399. The total value of stock exercises is $12,487,973.


1 year stock price chart,   1 day stock price chart
opopp
opopopop

Figure 1. Monthly insider transaction values at Regeneron Pharmaceuticals Inc (REGN) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • $3,371k

    $337k

    $33k

    $3k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at Regeneron Pharmaceuticals Inc (REGN) in the past 24 months. See table 2 for insider transaction details.

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • $25.16

    $18.87

    $12.58

    $6.29



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Regeneron Pharmaceuticals Inc (REGN).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2009-09 0 0 15,900 263,176 0 0
2008-10 0 0 59,487 1,288,108 58,987 668,348
2008-09 0 0 30,001 681,022 138,002 1,102,736
2008-08 0 0 0 0 34,840 226,460
2008-05 0 0 15,000 297,535 15,000 137,550
2008-02 0 0 10,000 188,460 16,666 131,778
2008-01 0 0 15,000 375,000 5,000 38,300
2007-12 0 0 0 0 37,370 322,316
2007-11 0 0 40,917 837,135 25,409 203,885
2007-10 0 0 30,000 550,020 30,000 229,800
2007-04 0 0 135,350 3,371,489 195,063 1,995,444
2007-02 0 0 18,600 398,873 18,600 183,768
2007-01 0 0 0 0 9,999 98,739
2006-11 0 0 100,108 2,295,407 207,275 1,869,989
2006-10 0 0 223,908 4,421,930 213,750 2,028,500
2006-09 0 0 37,561 602,061 20,000 190,000
2006-08 0 0 2,000 30,000 0 0
2006-03 0 0 11,844 204,643 10,000 79,070
2006-02 0 0 34,599 545,852 50,000 416,400
2006-01 0 0 33,630 548,841 79,100 843,640
2005-12 0 0 21,142 293,109 135,000 1,721,250
2005-11 0 0 7,527,050 83,249,173 0 0
2005-08 0 0 10,677 101,399 0 0
2005-07 0 0 3,798 37,166 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for Regeneron Pharmaceuticals Inc (REGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-09-13 Schleifer Leonard S (Chief Exec Officer & President) Sale 15,900 16.55 263,176
2008-10-01 Mccorkle Douglas S (VP, Controller and Asst. Treas) Sale 32,664 21.64 707,912
2008-10-01 Mccorkle Douglas S (VP, Controller and Asst. Treas) Option Exercise 32,664 11.26 371,314
2008-10-01 Goldstein Joseph L (Director) Sale 500 22.32 11,160
2008-09-30 Stahl Neil (SVP, Research & Devel Sciences) Sale 10,317 21.68 223,696
2008-09-29 Stahl Neil (SVP, Research & Devel Sciences) Option Exercise 25,000 8.77 219,250
2008-09-29 Schleifer Leonard S (Chief Exec Officer & President) Option Exercise 73,010 7.41 541,004
2008-09-22 Roberts William (VP, Regul Devel & Med Safety) Sale 9,692 22.84 221,365
2008-09-19 Kolinski Stuart (SVP, Gen Counsel & Secretary) Sale 9,992 23.62 235,961
2008-09-19 Kolinski Stuart (SVP, Gen Counsel & Secretary) Option Exercise 9,992 8.50 84,932
2008-09-16 Roberts William (VP, Regul Devel & Med Safety) Option Exercise 25,000 8.77 219,250
2008-09-09 Brown Michael S (Director) Option Exercise 5,000 7.66 38,300
2008-08-20 Roberts William (VP, Regul Devel & Med Safety) Option Exercise 34,840 6.50 226,460
2008-05-30 Shooter Eric M (Director) Sale 15,000 19.84 297,535
2008-05-30 Shooter Eric M (Director) Option Exercise 15,000 9.17 137,550
2008-02-27 Vagelos P Roy (Director) Option Exercise 6,666 7.91 52,708
2008-02-15 Baker Charles A (Director) Sale 10,000 18.85 188,460
2008-02-15 Baker Charles A (Director) Option Exercise 10,000 7.91 79,070
2008-01-22 Goldstein Joseph L (Director) Sale 5,000 25.00 125,000
2008-01-22 Goldstein Joseph L (Director) Option Exercise 5,000 7.66 38,300
2008-01-22 Brown Michael S (Director) Sale 9,800 25.00 245,000
2008-01-17 Brown Michael S (Director) Sale 200 25.00 5,000
2007-12-20 Schleifer Leonard S (Chief Exec Officer & President) Option Exercise 37,370 8.62 322,316
2007-11-06 Brown Michael S (Director) Sale 6,108 19.65 119,999
2007-11-05 Goldstein Joseph L (Director) Sale 5,000 20.62 102,807
2007-11-05 Goldstein Joseph L (Director) Option Exercise 5,000 7.66 38,300
2007-11-05 Brown Michael S (Director) Sale 10,000 20.63 205,071
2007-11-05 Brown Michael S (Director) Option Exercise 10,000 7.91 79,100
2007-11-02 Mccorkle Douglas S (VP, Controller and Asst. Treas) Sale 6,209 21.00 130,412
2007-11-02 Mccorkle Douglas S (VP, Controller and Asst. Treas) Option Exercise 6,209 8.75 54,313
2007-10-02 Shooter Eric M (Director) Sale 20,000 18.33 366,680
2007-10-02 Shooter Eric M (Director) Option Exercise 20,000 7.66 153,200
2007-04-26 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Sale 8,931 27.16 242,586
2007-04-25 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Option Exercise 20,189 9.13 184,325
2007-04-23 Stahl Neil (SVP, Research & Devel Sciences) Sale 10,988 25.55 280,785
2007-04-23 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Sale 4,835 25.56 123,578
2007-04-20 Stahl Neil (SVP, Research & Devel Sciences) Option Exercise 25,000 8.77 219,250
2007-04-20 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Option Exercise 11,000 8.77 96,470
2007-04-16 Yancopoulos George (EVP, CSO, & Pres Regn Res Labs) Sale 31,283 24.79 769,021
2007-04-13 Yancopoulos George (EVP, CSO, & Pres Regn Res Labs) Option Exercise 90,444 10.56 955,359
2007-04-13 Rupp Randall (SVP, Manufuring Operations) Sale 31,250 24.94 779,406
2007-04-13 Rupp Randall (SVP, Manufuring Operations) Option Exercise 31,250 11.95 373,343
2007-04-13 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Sale 7,624 24.84 189,346
2007-04-13 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Option Exercise 7,624 8.62 65,757
2007-04-09 Yancopoulos George (EVP, CSO, & Pres Regn Res Labs) Sale 9,556 23.83 227,743
2007-04-09 Yancopoulos George (EVP, CSO, & Pres Regn Res Labs) Option Exercise 9,556 10.56 100,940
2007-02-26 Gilman Alfred G (Director) Sale 10,000 21.49 214,518
2007-02-26 Gilman Alfred G (Director) Option Exercise 10,000 9.88 98,800
2007-01-30 Vagelos P Roy (Director) Option Exercise 6,666 9.88 65,826
2006-11-21 Shooter Eric M (Director) Sale 10,000 22.85 228,488
2006-11-21 Shooter Eric M (Director) Option Exercise 10,000 9.88 98,750
2006-11-20 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Sale 1,200 24.76 29,712
2006-11-20 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Option Exercise 6,200 8.32 51,591
2006-11-08 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Sale 4,065 23.56 95,924
2006-11-07 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Sale 8,797 23.32 205,172
2006-11-07 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Option Exercise 10,176 8.67 88,259
2006-11-07 Schleifer Leonard S (Chief Exec Officer & President) Sale 53,986 23.12 1,247,920
2006-11-06 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Sale 10,000 22.75 227,500
2006-11-06 Goldberg Murray A (SVP Fin & Admin, CFO, & Treas) Option Exercise 30,899 8.80 272,014
2006-11-06 Schleifer Leonard S (Chief Exec Officer & President) Option Exercise 150,000 9.06 1,359,375
2006-11-06 Brown Michael S (Director) Sale 5,000 23.00 115,000
2006-11-01 Stahl Neil (SVP, Therap & Clin Prog Dev) Sale 5,760 20.00 115,200
2006-10-31 Stahl Neil (SVP, Therap & Clin Prog Dev) Sale 41,689 20.07 836,537
2006-10-31 Stahl Neil (SVP, Therap & Clin Prog Dev) Option Exercise 60,000 10.49 629,224
2006-10-31 Rupp Randall (SVP, Manufuring Operations) Sale 143,750 20.04 2,881,201
2006-10-31 Rupp Randall (SVP, Manufuring Operations) Option Exercise 143,750 9.05 1,300,526
2006-10-31 Brown Michael S (Director) Sale 4,000 20.00 80,000
2006-10-19 Brown Michael S (Director) Sale 2,000 19.50 39,000
2006-10-18 Brown Michael S (Director) Sale 2,469 18.00 44,442
2006-10-17 Schleifer Leonard S (Chief Exec Officer & President) Sale 30,000 18.02 540,750
2006-10-17 Brown Michael S (Director) Option Exercise 10,000 9.88 98,750
2006-09-13 Schleifer Leonard S (Chief Exec Officer & President) Sale 14,100 16.55 233,372
2006-09-01 Rupp Randall (SVP, Manufuring Operations) Sale 23,461 15.72 368,689
2006-09-01 Rupp Randall (SVP, Manufuring Operations) Option Exercise 20,000 9.50 190,000
2006-08-17 Kolinski Stuart (VP, Gen Counsel & Secretary) Sale 2,000 15.00 30,000
2006-03-16 Brown Michael S (Director) Sale 1,721 17.00 29,257
2006-03-14 Brown Michael S (Director) Sale 1,537 17.00 26,129
2006-03-10 Shooter Eric M (Director) Sale 5,283 17.00 89,803
2006-03-09 Shooter Eric M (Director) Option Exercise 10,000 7.91 79,070
2006-03-07 Schleifer Leonard S (Chief Exec Officer & President) Sale 802 18.00 14,436
2006-03-06 Schleifer Leonard S (Chief Exec Officer & President) Sale 1,400 18.00 25,200
2006-02-06 Stahl Neil (Biomol Sci) Sale 8,599 16.12 138,572
2006-02-03 Stahl Neil (Biomol Sci) Sale 16,000 15.86 253,760
2006-02-03 Stahl Neil (Biomol Sci) Option Exercise 40,000 7.41 296,400
2006-02-01 Baker Charles A (Director) Sale 10,000 15.35 153,520
2006-02-01 Baker Charles A (Director) Option Exercise 10,000 12.00 120,000
2006-01-09 Yancopoulos George (EVP, CSO, & Pres Reg) Sale 900 17.24 15,512
2006-01-09 Stahl Neil (Biomol Sci) Sale 1,744 17.24 30,059
2006-01-09 Rupp Randall (SVP, Manufuring Ope) Sale 1,682 16.88 28,392
2006-01-09 Kolinski Stuart (Secretary) Sale 1,621 17.24 27,939
2006-01-09 Goldberg Murray A (Treas) Sale 2,177 17.24 37,522
2006-01-09 Sing George L (Director) Option Exercise 40,000 9.36 374,440
2006-01-09 Brown Michael S (Director) Option Exercise 10,000 12.00 120,000
2006-01-06 Gilman Alfred G (Director) Sale 10,000 16.26 161,386
2006-01-06 Gilman Alfred G (Director) Option Exercise 10,000 12.00 120,000
2006-01-05 Rupp Randall (SVP, Manufuring Ope) Sale 4,000 15.80 63,200
2006-01-04 Shooter Eric M (Director) Sale 2,406 15.89 38,221
2006-01-03 Shooter Eric M (Director) Option Exercise 10,000 12.00 120,000
2005-12-27 Yancopoulos George (EVP, CSO, & Pres Reg) Sale 5,500 14.87 81,801
2005-12-27 Yancopoulos George (EVP, CSO, & Pres Reg) Option Exercise 25,000 12.75 318,750
2005-12-27 Kolinski Stuart (Secretary) Sale 3,000 15.00 45,000
2005-12-27 Goldberg Murray A (Treas) Sale 492 14.94 7,350
2005-12-27 Schleifer Leonard S (Chief Exec Officer &) Option Exercise 80,000 12.75 1,020,000
2005-12-23 Goldberg Murray A (Treas) Sale 12,150 13.08 158,958
2005-12-23 Goldberg Murray A (Treas) Option Exercise 30,000 12.75 382,500
2005-11-08 Novartis Pharma Ag (10% Owner) Sale 7,527,050 11.06 83,249,173
2005-08-05 Stahl Neil (Biomol Sci) Sale 10,677 9.50 101,399
2005-07-20 Goldberg Murray A (Treas) Sale 2,177 10.00 21,770
2005-07-11 Kolinski Stuart (Secretary) Sale 1,621 9.50 15,396

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regeneron Pharmaceuticals Inc (symbol REGN, CIK number 872589) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.